Tolvaptan in euvolemic hyponatremia (DrugBank: Tolvaptan)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
72 | 下垂体性ADH分泌異常症 | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01425125 (ClinicalTrials.gov) | November 2011 | 25/8/2011 | Fractional Urate Excretion in Nonedematous Hyponatremia | Study of Nonedematous Hyponatremia and the Utility of Fractional Urate Excretion in Hyponatremia and Suspected Renal Salt Wasting Without Hyponatremia- | Cerebral Hyponatremia;SIADH;Cerebral Salt-wasting Syndrome;Reset Hypothalamic Osmostat | Drug: Tolvaptan in euvolemic hyponatremia | NYU Langone Health | NULL | Withdrawn | 18 Years | N/A | All | 0 | N/A | United States |